Stay updated on Faricimab in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section now clarifies that some results publications are provided voluntarily by the data submitter and that others are auto-filled from PubMed. The revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange Detected- The government's funding status notice has been removed from the page. The TENAYA trial details remain unaffected and continue to be presented.SummaryDifference0.1%

- Check34 days agoChange DetectedAdministrative updates to the study page, including the last update posted date and minor text edits in the Study Overview and Study Record. These changes do not affect the study's design, eligibility criteria, outcomes, or results.SummaryDifference0.2%

- Check62 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference0.9%

- Check69 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.0%

- Check83 days agoChange DetectedThe update primarily localizes the location label to 'México' (instead of 'Mexico') while preserving the rest of the address; the page revision is bumped to v3.0.2. A non-critical navigation element 'Back to Top' was removed.SummaryDifference0.1%

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.